Michael Zinda - 15 Mar 2022 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
EVP, Chief Science Officer
Signature
/s/ Steve Forte, Attorney-in-Fact
Issuer symbol
RPTX
Transactions as of
15 Mar 2022
Net transactions value
-$6,023
Form type
4
Filing time
16 Mar 2022, 16:04:49 UTC
Previous filing
20 Jan 2022
Next filing
01 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Shares Sale $6,023 -533 -1.1% $11.30 46,041 15 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.